- Home
- CTNM vs OPP Comparison
CTNM vs OPP Comparison
Compare CTNM & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- OPP
- Stock Information
- Founded
- CTNM 2009
- OPP 2010
- Country
- CTNM United States
- OPP United States
- Employees
- CTNM N/A
- OPP N/A
- Industry
- CTNM
- OPP Finance/Investors Services
- Sector
- CTNM
- OPP Finance
- Exchange
- CTNM Nasdaq
- OPP Nasdaq
- Market Cap
- CTNM 199.3M
- OPP 204.1M
- IPO Year
- CTNM 2024
- OPP N/A
- Fundamental
- Price
- CTNM $7.59
- OPP $8.54
- Analyst Decision
- CTNM Strong Buy
- OPP
- Analyst Count
- CTNM 4
- OPP 0
- Target Price
- CTNM $29.25
- OPP N/A
- AVG Volume (30 Days)
- CTNM 56.2K
- OPP 108.0K
- Earning Date
- CTNM 03-04-2025
- OPP 01-01-0001
- Dividend Yield
- CTNM N/A
- OPP 14.41%
- EPS Growth
- CTNM N/A
- OPP N/A
- EPS
- CTNM N/A
- OPP N/A
- Revenue
- CTNM N/A
- OPP N/A
- Revenue This Year
- CTNM N/A
- OPP N/A
- Revenue Next Year
- CTNM N/A
- OPP N/A
- P/E Ratio
- CTNM N/A
- OPP N/A
- Revenue Growth
- CTNM N/A
- OPP N/A
- 52 Week Low
- CTNM $7.04
- OPP $7.26
- 52 Week High
- CTNM $22.00
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- OPP 50.73
- Support Level
- CTNM N/A
- OPP $8.53
- Resistance Level
- CTNM N/A
- OPP $8.77
- Average True Range (ATR)
- CTNM 0.00
- OPP 0.07
- MACD
- CTNM 0.00
- OPP -0.01
- Stochastic Oscillator
- CTNM 0.00
- OPP 17.86
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.